Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents and antipsychotic drugs. Its structure supports the creation of bioactive molecules due to the presence of the trifluoromethyl group, which enhances metabolic stability and membrane permeability. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies involving pyrrolidine-based compounds. Also utilized in the preparation of enzyme inhibitors and receptor modulators, especially targeting dopamine and serotonin receptors. Suitable for use in asymmetric synthesis and catalysis due to its chiral center.